• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.甲状腺功能异常性视神经病变的临床特征:欧洲Graves眼病研究组(EUGOGO)调查
Br J Ophthalmol. 2007 Apr;91(4):455-8. doi: 10.1136/bjo.2006.094607. Epub 2006 Oct 11.
2
[Clinical characteristics of dysthyroid optic neuropathy].[甲状腺功能异常性视神经病变的临床特征]
Harefuah. 2015 Feb;154(2):98-102, 137.
3
Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.威胁视力的格雷夫斯眼病:多学科甲状腺眼病门诊 20 年的经验。
Clin Endocrinol (Oxf). 2019 Jan;90(1):208-213. doi: 10.1111/cen.13880. Epub 2018 Nov 19.
4
Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.甲状腺相关眼病的诊断方法:系统评价与分析。
Surv Ophthalmol. 2024 May-Jun;69(3):403-410. doi: 10.1016/j.survophthal.2023.11.009. Epub 2023 Nov 23.
5
Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.将恢复视力作为甲状腺功能异常性视神经病变患者治疗的主要目标。
Endokrynol Pol. 2016;67(2):166-73. doi: 10.5603/EP.a2016.0018. Epub 2016 Feb 17.
6
Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients.三级中心甲状腺相关眼病视神经病变 6 个月显著恢复的预后因素:38 例 69 眼系列。
Ann Endocrinol (Paris). 2023 Aug;84(4):430-439. doi: 10.1016/j.ando.2023.04.002. Epub 2023 Apr 21.
7
Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.甲状腺相关眼病所致压迫性视神经病变的光学相干断层扫描测量
Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1617-1624. doi: 10.1007/s00417-016-3335-9. Epub 2016 May 12.
8
Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.甲状腺功能异常性视神经病变:非典型的初始表现及持续性视力丧失。
Orbit. 2009;28(6):354-62. doi: 10.3109/01676830903104728.
9
Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy.亚临床甲状腺毒性视神经病变:三原色缺失作为甲状腺毒性视神经病变的早期征象。
Br J Ophthalmol. 2021 Jul;105(7):1019-1023. doi: 10.1136/bjophthalmol-2020-316433. Epub 2020 Jul 22.
10
Dysthyroid optic neuropathy: evaluation and management.甲状腺相关眼病:评估与管理。
J Endocrinol Invest. 2021 Mar;44(3):421-429. doi: 10.1007/s40618-020-01361-y. Epub 2020 Jul 29.

引用本文的文献

1
Exploring thyroid eye disease in Brazil: insights from a single-center study.探索巴西的甲状腺眼病:一项单中心研究的见解
Arch Endocrinol Metab. 2025 Aug 20;69(3):e240495. doi: 10.20945/2359-4292-2024-0495.
2
Predictive demographic and clinical features for the development of dysthyroid optic neuropathy in a multi-ethnic TED population: a retrospective cohort study.多民族甲状腺相关眼病患者发生甲状腺功能障碍性视神经病变的预测性人口统计学和临床特征:一项回顾性队列研究
Thyroid Res. 2025 Jul 22;18(1):37. doi: 10.1186/s13044-025-00249-4.
3
Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy.磁共振成像在甲状腺相关性眼病中的应用进展
Front Endocrinol (Lausanne). 2025 Jun 26;16:1537957. doi: 10.3389/fendo.2025.1537957. eCollection 2025.
4
Lamina cribrosa curvature depth and index as novel parameters in Graves' ophthalmopathy.筛板曲率深度和指数作为Graves眼病的新参数
Sci Rep. 2025 Jul 2;15(1):22981. doi: 10.1038/s41598-025-06584-8.
5
Predicting visual acuity recovery in orbital decompression surgery for dysthyroid optic neuropathy.甲状腺相关性眼病性视神经病变眼眶减压手术中视力恢复的预测
Thyroid Res. 2025 Jul 1;18(1):33. doi: 10.1186/s13044-025-00248-5.
6
Inflammatory Proteins Mediate the Effect of Gut Microbiota on Graves' Ophthalmopathy: A Mendelian Randomization Study.炎症蛋白介导肠道微生物群对格雷夫斯眼病的影响:一项孟德尔随机化研究。
Transl Vis Sci Technol. 2025 Jun 2;14(6):34. doi: 10.1167/tvst.14.6.34.
7
Alterations in blood flow at the optic nerve head in patients with thyroid eye disease using optic coherence tomography angiography.使用光学相干断层扫描血管造影术观察甲状腺眼病患者视神经乳头血流的变化。
Front Med (Lausanne). 2025 May 30;12:1585907. doi: 10.3389/fmed.2025.1585907. eCollection 2025.
8
Radiological Activity Score (RAS)-MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi-Ethnic Thyroid Eye Disease Population.多民族甲状腺眼病患者甲状腺功能异常性视神经病变的放射学活动评分(RAS)-MRI特征
Clin Endocrinol (Oxf). 2025 Sep;103(3):385-395. doi: 10.1111/cen.15272. Epub 2025 May 20.
9
Inflammatory profiling and immune cell infiltration in dysthyroid optic neuropathy: insights from bulk RNA sequencing.甲状腺功能异常性视神经病变中的炎症特征分析及免疫细胞浸润:来自全转录组RNA测序的见解
Front Immunol. 2025 Mar 12;16:1550694. doi: 10.3389/fimmu.2025.1550694. eCollection 2025.
10
Orbital Clinicopathological Differences in Thyroid Eye Disease: An Analysis of Cytokines With Histopathological and Clinical Correlation.甲状腺眼病的眼眶临床病理差异:细胞因子与组织病理学及临床相关性分析
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):33. doi: 10.1167/iovs.66.3.33.

本文引用的文献

1
Thyroid-associated orbitopathy: a clinicopathologic and therapeutic review.甲状腺相关眼病:临床病理与治疗综述
Curr Opin Ophthalmol. 2004 Oct;15(5):389-400. doi: 10.1097/01.icu.0000139992.15463.1b.
2
Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory study.荷兰健康人群及格雷夫斯病患者眼球突出度测量的可靠性及眼球突出度值分布:一项探索性研究。
Orbit. 2004 Sep;23(3):161-8. doi: 10.1080/01676830490504089.
3
Graves' ophthalmopathy: state of the art and perspectives.格雷夫斯眼病:最新进展与展望
J Endocrinol Invest. 2004 Mar;27(3):295-301. doi: 10.1007/BF03345280.
4
Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients.格雷夫斯病性视神经病变:215例经鼻窦眼眶减压术的结果及长期随访
Am J Ophthalmol. 2003 Sep;136(3):433-41. doi: 10.1016/s0002-9394(03)00233-2.
5
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.格雷夫斯眼眶病患者特征及治疗策略的多中心研究:欧洲格雷夫斯眼眶病研究组的首次经验
Eur J Endocrinol. 2003 May;148(5):491-5. doi: 10.1530/eje.0.1480491.
6
Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.伴有高眼压及疑似青光眼或甲状腺功能异常性视神经病变的格雷夫斯眼病患者的视觉诱发电位
Doc Ophthalmol. 2003 Mar;106(2):99-104. doi: 10.1023/a:1022561530782.
7
CT scan evidence of dysthyroid optic neuropathy.甲状腺功能异常性视神经病变的CT扫描证据。
Ophthalmic Plast Reconstr Surg. 2002 May;18(3):177-82. doi: 10.1097/00002341-200205000-00005.
8
Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment.活动性甲状腺相关性眼病临床评估中的争议:使用带有对比照片的详细方案进行客观评估。
Clin Endocrinol (Oxf). 2001 Sep;55(3):283-303. doi: 10.1046/j.1365-2265.2001.01349.x.
9
Results of transmedial-canthal ethmoidal decompression for severe dysthyroid optic neuropathy.经内眦筛窦减压术治疗重度甲状腺功能障碍性视神经病变的结果
Jpn J Ophthalmol. 1999 Sep-Oct;43(5):426-32. doi: 10.1016/s0021-5155(99)00091-x.
10
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.临床活动评分作为格雷夫斯眼病患者管理的指导
Clin Endocrinol (Oxf). 1997 Jul;47(1):9-14. doi: 10.1046/j.1365-2265.1997.2331047.x.

甲状腺功能异常性视神经病变的临床特征:欧洲Graves眼病研究组(EUGOGO)调查

Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.

作者信息

McKeag David, Lane Carol, Lazarus John H, Baldeschi Lelio, Boboridis Kostas, Dickinson A Jane, Hullo A Iain, Kahaly George, Krassas Gerry, Marcocci Claudio, Marinò Michele, Mourits Maarten P, Nardi Marco, Neoh Christopher, Orgiazzi Jacques, Perros Petros, Pinchera Aldo, Pitz Susanne, Prummel Mark F, Sartini Maria S, Wiersinga Wilmar M

机构信息

Centre for Endocrine and Diabetes Sciences, University Hospital of Wales, Cardiff CF 4 4XN, UK.

出版信息

Br J Ophthalmol. 2007 Apr;91(4):455-8. doi: 10.1136/bjo.2006.094607. Epub 2006 Oct 11.

DOI:10.1136/bjo.2006.094607
PMID:17035276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1994756/
Abstract

BACKGROUND

This study was performed to determine clinical features of dysthyroid optic neuropathy (DON) across Europe.

METHODS

Forty seven patients with DON presented to seven European centres during one year. Local protocols for thyroid status, ophthalmic examination and further investigation were used. Each eye was classified as having definite, equivocal, or no DON.

RESULTS

Graves' hyperthyroidism occurred in the majority; 20% had received radioiodine. Of 94 eyes, 55 had definite and 17 equivocal DON. Median Clinical Activity Score was 4/7 but 25% scored 3 or less, indicating severe inflammation was not essential. Best corrected visual acuity was 6/9 (Snellen) or worse in 75% of DON eyes. Colour vision was reduced in 33 eyes, of which all but one had DON. Half of the DON eyes had normal optic disc appearance. In DON eyes proptosis was > 21 mm (significant) in 66% and visual fields abnormal in 71%. Orbital imaging showed apical muscle crowding in 88% of DON patients. Optic nerve stretch and fat prolapse were infrequently reported.

CONCLUSION

Patients with DON may not have severe proptosis and orbital inflammation. Optic disc swelling, impaired colour vision and radiological evidence of apical optic nerve compression are the most useful clinical features in this series.

摘要

背景

本研究旨在确定欧洲范围内甲状腺功能异常性视神经病变(DON)的临床特征。

方法

一年内,47例DON患者前往欧洲七个中心就诊。采用当地关于甲状腺状态、眼科检查及进一步检查的方案。每只眼睛被分类为患有明确的、可疑的或无DON。

结果

大多数患者为格雷夫斯甲亢;20%曾接受放射性碘治疗。在94只眼中,55只患有明确的DON,17只患有可疑的DON。临床活动评分中位数为4/7,但25%的患者评分为3分或更低,这表明严重炎症并非必要条件。75%的DON患眼最佳矫正视力为6/9(斯内伦视力表)或更差。33只眼睛的色觉减退,其中除一只外均患有DON。一半的DON患眼视盘外观正常。在DON患眼中,66%的患者眼球突出>21mm(显著),71%的患者视野异常。眼眶成像显示88%的DON患者存在眶尖肌肉拥挤。视神经牵拉和脂肪脱垂的报告较少。

结论

DON患者可能没有严重的眼球突出和眼眶炎症。视盘肿胀、色觉受损以及眶尖视神经受压的影像学证据是本系列中最有用的临床特征。